维普中文期刊产品整合服务
29篇 您的检索式:作者名="Yap MA"
    题名 作者 年代 出处 被引量
1The impact of PET on the management of lung cancer: the referring physician'perspective 显示文摘Seltzer MA Yap CS Silverman DH 2003Nucl Med2003,43,6:1
2The impact of PET on the management of lung cancer: the referring physician's perspective显示文摘Seltzer MA Yap CS Silverman DH 2002J Nucl Med2002,43,6:1
3Survival analysis and causes of mortality in patients with lupus nephritis 显示文摘Yap DYH Tang CSO Ma MKM 2012Nephrology Dialysis Transplantation2012,27,8:1
4The impact of PET on the management of lung cancer: the referring physician's perspective显示文摘Seltzer MA Yap CS Silverman DH 2002J Nucl Med2002,43,6:1
5The impact of PET on the management of lung cancer:the referring physixian perspective显示文摘Seltzer MA Yap CS Silverman DH 2002J Nucl MED2002,43,6:1
6Proliferation signal inhibitors inthe treatment of lupus nephritis:preliminary experience显示文摘Yap DY Ma MK Tang CS 2012Neph-rology(Carlton)2012,17,8:1
7The impact of PET on the management of lung cancer: the referring physician's perspective 显示文摘Seltzer MA Yap CS Silverman DH 2002J Nucl Med2002,43,6:1
8Urinary metabolic phenotyping differen- tiates children with autism from their unaffected siblings and age-matched controls 显示文摘Ivan KS Yap MA 2010Journal of Proteorne Re- search2010,9,:1
9Long-term data on tacroli-mus treatment in lupus nephritis显示文摘Yap DY Ma MK Mok MM 2014Rheumatology2014,53,12:1
10The impact of PET on the management of lung cancer: the referring physician's perspective显示文摘Tzer MA Yap CS Silverman DH 2002J Nucl Med2002,43,6:1
11Survival analysis and causes of mortality in patients with lupus nephritis 显示文摘Yap DY Tang CS Ma MK 2012Nephrol Dial Trans- plant2012,27,8:1
12The impact of PET on the management of lung cancer:the referring physician's perspective显示文摘Seltzer MA Yap CS Silverman DH 2002J Nucl Med2002,43,6:1
13Survival analysis and causes of mortality in patients with lupus nephritis 显示文摘Yap DY Tang CS Ma MK 2012Nephrol Dial Transplant2012,27,:1
14Reduction of CO2 using a rhenium bipyridine complex containing ancillary BODIPY moieties显示文摘Teesdale J J Pistner A J Yap G P A Ma Y Z Lutterman D A Rosenthal J 2014Catalysis Today2014,225,:1
15Impact of whole-body is F-FDG PET on staging and managing patients with breast cancer: the referring physician' sperspective 显示文摘Yap CS Seltzer MA Schiepers C 2001J Nucl Med2001,42,9:1
16The impact of PET on the management of lung cancer:the referring physician's perspective显示文摘Seltzer MA Yap CS Silverman DH 2002J Nucl Med2002,43,6:1
17Proliferation signal inhibitors in the treatment of lupus nephritis: preliminary experience显示文摘Yap DY Ma MK Tang CS 2012Nephrology(Carlton)2012,17,8:1
18Survival analysis and causes of mortality in patients with lupus nephritis显示文摘Yap DY Tang CS Ma MK 0,,:1
19The impact of PET on the management of lung cancer: the referring physician' perspective显示文摘Seltzer MA Yap CS Silveman DH 2002J Nucl Med2002,43,6:1
20Impact of whole-body18F-FDG PET on staging and managing patients with breast cancer:the referring physician's perspective显示文摘Yap CS Seltzer MA Schiepers C 2001J Nucl Med2001,42,9:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费